Company News
-
May 19, 2025
bioMérieux Partners with First U.S. Hospital to Use VITEK® REVEAL™ Fast AST for Blood Stream Infections
bioMérieux is partnering with AdventHealth Orlando as they become the first institution to adopt the VITEK® REVEAL™ Fast Antimicrobial Susceptibility Testing (AST) System for clinical use in the United States.
-
February 24, 2025
bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases
bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation. -
January 07, 2025
bioMérieux, Tampa General Hospital and USF Health Host AMR Summit to Drive Action on Antimicrobial Resistance
bioMérieux, Tampa General Hospital (TGH) and USF Health hosted the inaugural U.S. AMR Summit Nov. 12-13 to address the escalating global threat of antimicrobial resistance (AMR).
-
November 28, 2024
With E-Resale, bioMérieux innovates by giving a second life to its instruments
Launched last July, starting with Africa and Middle East, the E-Resale platform allows to purchase and sell second-hand bioMérieux instruments for clinical applications. This is an innovative offer in the field of circular economy and a first on the in vitro diagnostics market. -
November 22, 2024
bioMérieux and St James’s Hospital in Ireland announce the world-first Data & IT Centre of Reference partnership
On November 14th, 2024, bioMérieux officially launched its first Data & IT Centre of Reference partnership with St James's Hospital in Dublin, Ireland. This landmark collaboration has been celebrated with an event held at the Davis Coakley Lecture Theatre, St James's Hospital.
Follow us on Socials for more news!